Fresh2 (FRES): Net earnings per share (EPS TTM)

Corporate emblem and logo of Fresh2 (FRES)

The annual net profit per share trend for Fresh2 Group Limited demonstrates resilience, bolstered by the protection of Chinese logistics networks and strict sanitary regulations. This momentum is based on the implementation of AI-driven supply chain optimization and cloud-based SaaS software. Partner trust ensures the transparency of the digital marketplace between farmers and retail. The value of 0.00 reflects the latest metric value, capturing the current financial efficiency of Fresh2 Group Limited.

FRES Fresh2 Net earnings per share for the last four quarters (02/21/2024 - 01/04/2025)
Mass-produced product of Fresh2 Group Ltd

Fresh2 Group Limited operates in the high-risk segment of Chinese Agro-IT. Net income per share (TTM) measures the portion of actual earnings attributable to a single security over the last twelve months. Investors utilize this filter to distinguish fair value from market speculation. For a small business with logistics costs, this metric is critical when searching for a fundamental bottom. The trend of the rolling annual income per share visualizes the company's resilience to regulatory pressure.

Competitors of Fresh2 Group Limited

A - Earnings per share for the last twelve months|Net earnings per share for the last four quarters questdiagnostics.com DGX|ILMN: Net earnings per share (EPS TTM)|EXAS - Net earnings per share for the last four quarters|Earnings per share for the last twelve months PerkinElmer|Bio-Rad Corp (BIO) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) NNNN|SHC: Earnings per one share for the last 12 months|Earnings per share for the last twelve months QuidelOrtho Corporation QDEL|Earnings per share for the trailing year OPK|CareDx Health - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Maravai|Fulgent Genetics, Inc. (FLGT) - Earnings per share for the last twelve months|LAB - Net earnings per share for the last four quarters|CTKB (Cytek Biosciences) - Net earnings per share (EPS TTM)|OSUR: Earnings per share for the trailing year|Earnings per share for the last twelve months Exagen Inc. (XGN)|Net earnings per share for the last 12 months MDxHealth, Inc. MDXH|Earnings per share for the trailing year Lucid Diagnostics Inc.|Net earnings per share (EPS TTM) Prenetics Global Limited PRE|Net earnings per share for the trailing year IMDX|TRIB: Earnings per share for the last twelve months|Earnings per share for the trailing year ProPhase PRPH|AIMD (Ainos Corporation) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months CODX (Co-Diagnostics, Inc.)|Net earnings per share for the last 12 months heartsciences.com (HSCS)|Net earnings per share (EPS TTM) BMRA|Earnings per share for the last twelve months CDIO (cardiodiagnosticsinc.com)|Onconetix Corp (ONCO) - Earnings per one share for the last 12 months|VRAX - Net earnings per share for the last 12 months|Earnings per share for the trailing year Bluejay Diagnostics (BJDX)|AWH: Earnings per share for the last twelve months|Accelerate Diagnostics, Inc. (AXDX) - Earnings per share for the last twelve months|centogene.com (CNTG) - Net earnings per share (EPS TTM)|ENZ: Net earnings per share for the last four quarters|Earnings per share for the last twelve months GENE|Net earnings per share for the last 12 months ME (23andMe Holding Co.)|Net earnings per share (EPS TTM) psychemedics.com (PMD)